Title : Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axis.

Pub. Date : 2022 Apr 26

PMID : 35467979






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Computational, preclinical, and patient tumor multiplexed analyses revealed that tumor-associated focal adhesion kinase (FAK) activation regulates CD155 expression, a checkpoint ligand for TIGIT (T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains). Tyrosine protein tyrosine kinase 2 Homo sapiens
2 Computational, preclinical, and patient tumor multiplexed analyses revealed that tumor-associated focal adhesion kinase (FAK) activation regulates CD155 expression, a checkpoint ligand for TIGIT (T cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains). Tyrosine protein tyrosine kinase 2 Homo sapiens